Review BoostingCancerImmunotherapywithAnti-CD137 Antibody Therapy Atsushi Yonezawa1,2, Suparna Dutt3, Cariad Chester1,4, Jeewon Kim5, and Holbrook E. Kohrt1 Abstract.Synthetic Lethality Exploitation by an Anti–Trop-2-SN-38 Antibody–Drug Conjugate, IMMU-132, Plus PARP Inhibitors in BRCA1/2–wild-type Triple-Negative Breast Cancer Thomas M. Cardillo, Robert M. Sharkey, Diane L. Rossi, Roberto Arrojo, Ali A. Mostafa, and David M. Goldenberg Abstract Purpose: Both PARP inhibitors (PARPi) and sacituzumab.
Trofiliste haavandite õigeaegne ravi ja haavandite varajases staadiumis erilise ravirežiimi järgimine viib selle kiirele sulgemisele. Pahaloomuline taassündimine Üheks alajäsemete troofiliste haavandite kohutavateks komplikatsioonideks tuleb pidada pahaloomuliseks degeneratsiooniks, mis esineb 1,6-3,5% juhtudel, kuid diagnoositakse kaugelearenenud staadiumis.Depression Research and Treatment is archived in Portico, which provides permanent archiving for electronic scholarly journals, as well as via the LOCKSS initiative. It operates a fully open access publishing model which allows open global access to its published content.